Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8662862 | International Journal of Cardiology | 2017 | 26 Pages |
Abstract
For ARVC patients, both missense and non-missense DSP mutations carry a high arrhythmic risk. Non-missense mutations are specifically associated with left-dominant forms. The presence of DSP non-missense mutations should alert to the likely development of LV dysfunction. These findings highlight the clinical relevance of genetic testing even after the clinical diagnosis of ARVC and the growing clinical impact of genetics.
Keywords
CMRSAECGDCMARVCSCDNSVTACADSPdesmoplakinLGE2DEImplantable cardioverter defibrillatorSignal-averaged ECGVentricular arrhythmiasleft ventricular dysfunctionlate gadolinium enhancementCardiac magnetic resonancetwo-dimensional echocardiographyRight ventricularleft ventricleVentricular tachycardiaNon-sustained ventricular tachycardiaICDaborted cardiac arrestSudden cardiac deatharrhythmogenic cardiomyopathyArrhythmogenic right ventricular cardiomyopathyDilated cardiomyopathyejection fraction
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Silvia Castelletti, Annina S. Vischer, Petros Syrris, Lia Crotti, Carla Spazzolini, Alice Ghidoni, Gianfranco Parati, Sharon Jenkins, Maria-Christina Kotta, William J. McKenna, Peter J. Schwartz, Antonis Pantazis,